Products 67005-97-4

CAS 67005-97-4 appears in our catalog under these names: N–Propargyladenosine, N6-Propargyladenosine, N-Propargyladenosine, 99.13%, N-Propargyladenosine, 98%, (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(prop-2-yn-1-ylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol, 98%. Offered by: GLPBio, Biosynth, MedChemExpress, Ambeed, BLDpharm. Available pack sizes: 10mg, 25mg, 50mg, 25 mg, 5 mg, 10 mg, 100mg, 250mg.

N–Propargyladenosine
GLPBio
  • size: 10mg, 25mg
  • Variants: 2
from 1088.49
View product
N6-Propargyladenosine
Biosynth
  • size: 25mg, 10mg, 50mg
  • Variants: 3
View product
N-Propargyladenosine, 99.13%
MedChemExpress
  • size: 25 mg, 5 mg, 10 mg
  • Variants: 3
from 598.33
View product
N-Propargyladenosine, 98%
Ambeed, Chemat
  • size: 10mg, 25mg, 50mg, 100mg
  • Variants: 8
from 442.69
View product
(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(prop-2-yn-1-ylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol, 98%
BLDpharm
  • size: 10mg, 25mg, 50mg, 100mg
  • Variants: 5
from 469.86
View product
Structural formula: {0} (CAS {1})

(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(prop-2-ynylamino)purin-9-yl]oxolane-3,4-diol (CAS 67005-97-4) is a chemical compound with the molecular formula C13H15N5O4 and a molecular weight of 305.29 g/mol. IUPAC name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(prop-2-ynylamino)purin-9-yl]oxolane-3,4-diol. InChIKey: JCLIMDWHRZIHMW-QYVSTXNMSA-N.

Identity
Molecular formulaC13H15N5O4
Molecular weight305.29 g/mol
IUPAC name(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(prop-2-ynylamino)purin-9-yl]oxolane-3,4-diol
InChIKeyJCLIMDWHRZIHMW-QYVSTXNMSA-N
SMILESC#CCNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O

Computed by PubChem (NCBI)

Synonyms: n6-propargyladenosine, N6-(2-Propynyl)adenosine, N6-Propargyl-adenosine, orb532419, orb1734892, orb1908644
Isomers (same molecular formula)
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-4-prop-2-ynoxyoxolan-3-ol C13H15N5O4
(E)-3-[[9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]prop-2-enal C13H15N5O4
(2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolane-2-carbonitrile C13H15N5O4
(2R,3S,5R)-5-(2-amino-6-prop-2-ynoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol C13H15N5O4
3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-methyl-5H-imidazo[1,2-a]purin-9-one C13H15N5O4
(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-prop-2-ynoxyoxolan-3-ol C13H15N5O4
1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-4-imino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile C13H15N5O4
2-amino-9-[(2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one C13H15N5O4